Polycystic ovary syndrome (PCOS) is a common reproductive and endocrine disease of unknown aetiology. Recently, epigenetic studies focusing on DNA methylation in PCOS have received much attention, but the mechanisms are still unclear. In the present study, we used the 5 -dihydrotestosterone-induced PCOS-like rat model and treated the rats with electro-acupuncture (EA). Rats were randomly divided into four groups -controls, diet-induced obesity, PCOS and PCOS+EA. We examined the reproductive, metabolic and behavioural phenotypes, validated the effect of EA, and explored the role of hypothalamic DNA methylation by analysing the methylation of global DNA and selected candidate genes. The PCOS rats presented with reproductive dysfunctions such as lack of regular oestrous cyclicity, metabolic disorders such as increased body weight and insulin resistance, and depression and anxiety-like behaviours. EA improved the reproductive functions, decreased body weight and improved experimental depressive behaviour.
of mental disorders such as depression and anxiety in PCOS patients (Cinar et al., 2011; Dokras, Clifton, Futterweit, & Wild, 2011; Kerchner, Lester, Stuart, & Dokras, 2009) .
Although the aetiology of PCOS is not clear, accumulating evidence suggests that PCOS is inheritable and that epigenetic factors contribute to its development. Epigenetic studies, especially of DNA methylation, have recently been undertaken in an attempt to better understand the development of PCOS. Epigenetics is the study of heritable modifications in gene function without changes to the sequence of the DNA, and of the various types of DNA modifications, methylation appears to be the most common and important. The process of methylation is completed by three main types of DNA methyltransferases (DNMTs): DNMT1, 3a and 3b. DNMT1 is the primary protein for maintaining the methylation state during cell division, while DNMT3a and 3b can catalyse at unmethylated CpG sites and are thus associated with de novo methylation. Although DNMTs are highly expressed in the process of cell division during embryonic development, studies have shown that in some postmitotic neurons the expression of DNMTs is still detectable and they play some role in the brain (Feng, Chang, Li, & Fan, 2005) .
Some methylation studies associated with PCOS have been reported. In 2010, Xu et al. performed the first global DNA methylation study in PCOS by examining the peripheral leukocytes of 40 PCOS patients, but no differences were found between the PCOS patients and the healthy group (Xu, Azziz, & Goodarzi, 2010) . Subsequent to this initial work, the PCOS characteristics related to tissue-specific DNA methylation were described (Christensen et al., 2009; Fan & Zhang, 2009 ) in human ovaries (Wang, Lacza, Sun, & Han, 2014; Yu et al., 2015) , adipose tissues (Kokosar et al., 2016; Kokosar et al., 2018) and whole blood (Li et al., 2017) . Numerous genes and CpG sites involved in signalling pathways related to immunity, inflammation and steroid production have been identified in relation to PCOS (Kokosar et al., 2016; Li et al., 2017; Yu et al., 2015) .
The hypothalamus plays a vital role in the regulation of reproduction and the endocrine system (Maffucci & Gore, 2009; Navarro & Tena-Sempere, 2011) , and it plays a central role in maintaining metabolic and energy homeostasis (Abdalla, 2017) . In addition, the hypothalamus is also a major brain region that is involved in the regulation of emotion and behaviours (Alvarez-Bolado & Celio, 2016; McHenry, Rubinow, & Stuber, 2015) . The neuroendocrine origin of PCOS has been shown to be an important aspect of the aetiology of PCOS, and increased secretion of gonadotropin releasing hormone (GnRH) by the hypothalamus plays an important role in this process.
The mechanisms behind these effects might involve negative feedback effects of progesterone, oestrogen and androgens (Azziz et al., 2016; Bao, Meynen, & Swaab, 2008; McCartney, Eagleson, & Marshall, 2002) .
Our previous studies on the hypothalamus showed that 3 months of dihydrotestosterone (DHT) treatment induces reproductive disturbances and other PCOS-like symptoms in female rats and leads to hyperactivity of GnRH neurons. In addition, decreased locomotive activity and anxiety-like behaviours were observed after both 1 week and 3 months of DHT treatment in female rats (Feng et al., 2009 (Feng et al., , 2011 .
However, further studies on the hypothalamus from the perspective of DNA methylation in relation to the pathogenesis of PCOS have been
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• What is the central question of this study?
What is the role of hypothalamic DNA methylation in the development of polycystic ovary syndrome (PCOS) and the response to electro-acupuncture treatment.
• What is the main finding and its importance?
Global DNA methylation and expression of DNA methyltransferases (DNMTs) were increased in PCOS-like rats, and electro-acupuncture (EA) decreased global DNA methylation and DNMT3b expression. Pyrosequencing showed that the DNA methylation of some PCOS candidate genes was changed in the PCOS and PCOS+EA groups, suggesting that hypothalamic DNA methylation plays an important role in the development of PCOS and in mediating the effects of electro-acupuncture treatment.
limited by a lack of clinical samples and appropriate animal models. In addition to whole-tissue DNA methylation screening, candidate gene loci correlated with major phenotypes of PCOS may also contribute to understanding the pathophysiology of PCOS.
Acupuncture is a popular traditional Chinese therapy for various gynaecological diseases and is applied widely throughout the world.
Our previous studies showed that low-frequency electro-acupuncture (EA, 2 Hz) and manual acupuncture could regulate hypothalamic neuroendocrine function through targeting different molecules (Feng et al., 2009 (Feng et al., , 2012 . Therefore, in the present study we have illustrated the roles of hypothalamic DNA methylation in the development of PCOS and the effect of EA treatment in a PCOS-like animal model.
MATERIALS AND METHODS
Ethical approval
All of the animal experimental procedures and protocols were approved by the Ethics Committee of the School of Basic Medical Sciences, Fudan University (No. 20130227-024) . The animals were properly handled, and all of the experimental procedures were according to the policies and regulations of Experimental Physiology.
Animals and treatment
Female Wistar rats (21 days old, Shanghai Slac Laboratory Animal Co., Ltd, Shanghai, China) were randomly divided into control, diet-induced obesity (DIO), PCOS and PCOS+EA groups (n = 7-9 per group). All rats were housed in 12 h light-12 h dark conditions with constant temperature (22 ± 2 • C) and humidity (45%-55%) and with free access to normal rodent chow and water. At postnatal day 21, rats in the PCOS and PCOS+EA groups were implanted with a sustained-release tube (Dow Corning, Midland, MI, USA; length: 0.7 cm, thickness: 0.8 mm, diameter: 3 mm) containing 15 mg DHT (cat. no. A8380, Sigma-Aldrich, St Louis, MO, USA) to be released over 90 days. The process of implantation was as follows: after transient anaesthesia by isoflurane (2% in a 1:1 mixture of oxygen or air, RWD Life Science Co., Shenzhen, China), a 2 cm × 2 cm area was exposed by removing the hair in the neck of the rats, a DHT tube was put into a 1 cm operative incision subcutaneously in the neck, and the skin was quickly sutured and sterilized with 75% alcohol. All rats were put into a warm container and then taken back to their cages when they regained consciousness.
The obesity model was established by feeding the rats a 60% fat diet (cat. no. D12492, Research Diets, Inc., New Brunswick, NJ, USA) for 3 months. PCOS+EA rats were given acupuncture treatment from week 9 to week 12 after implantation of the DHT tube.
The acupoints used in the EA treatment were bilateral 'Sanyinjiao' (SP6), bilateral 'Guilai' (ST29) and 'Baihui' (DU20). The needles in acupoints SP6 and ST29 were attached to an electrical stimulator (HANSLH202, Huayang Co., Ltd, Beijing, China), while the needle at DU20 was only stimulated by manual rotation. Acupuncture needles were inserted to a depth of 0.5-0.8 cm in the posterior part of the medial tibia for SP6, in the bilateral part below the umbilical for ST29, and at the midpoint of the tips of the ears for DU20. EA was performed for 30 min per day from Monday to Friday, and the treatment lasted for 4 weeks. The frequency was 2 Hz, and the intensity was 1-2 mA.
All the needles (Suzhou Medical Appliance Factory, Suzhou, China) used were sterile, and the acupuncture manipulation was based strictly on the theory of traditional Chinese medicine. After transient anaesthesia by isoflurane (2% in a 1:1 mixture of oxygen and air), the rats were placed in a fabric harness and suspended above the desk, and the EA treatment was performed on the rats while they were in a conscious state. The same handling and anaesthetization -except for the acupuncture stimulation -was performed in the other three groups. At the end of the experiment, all rats were killed by deep anaesthesia by injecting 2% pentobarbital sodium solution (70 mg (kg body weight) −1 ) intraperitoneally, and the degree of anaesthesia was checked so as to ensure no pain or distress before tissue collection.
Trunk blood was collected, and the hypothalamus and ovaries were dissected. The dissected hypothalamus on ice was cut into halves immediately (half for PCR, half for western blot), put into liquid nitrogen, and transferred to −80 • C until further analysis. One side of the ovaries was post-fixed in 4% paraformaldehyde or hydrogel for haematoxylin and eosin (H&E) staining and CLARITY treatment. All samples from rats in the control and DIO groups were collected in the dioestrus stage of the oestrous cycle.
Vaginal smears
Vaginal smears were carried out to determine the oestrous stage from 
Behavioural tests
All rats were habituated to the laboratory environment for 1 h before testing each day, and the experiments were performed during the light period of the regular light-dark cycle. All behavioural results were recorded with a video camera (D70, Canon, Tokyo, Japan) that was fixed so as to record the entire experiment without disturbing the animals.
Forced swimming test
A glass cylinder (height: 45 cm, diameter: 18 cm) was used in the forced swimming test. All rats in the four groups underwent a 5 day adaptation period, and the time was the same as that of the final test. Rats were put into the cylinder with a water temperature of 25 • C and a depth of 35 cm, and the rats could not jump out and their hind paws could not touch the bottom of the cylinder during the test. The immobility time was recorded as the length of time the rat floated passively without movement. The whole test lasted for 5 min after each rat was put into the cylinder, and they were towel dried and kept warm before putting them back in their cages.
Sucrose preference test
An adaptation for 72 h was performed before the sucrose preference test. During the training process, two bottles of sucrose (200 ml/bottle, 1%, w/v) were put in each cage, and these were then replaced by one bottle of 1% sucrose and one bottle of tap water 24 h later. The sucrose preference test took place 1 day after the end of the adaptation period.
At the beginning of the test, one bottle of 1% sucrose and one bottle of tap water were placed in each cage, and 24 h later they were removed. The percentage of sucrose preference was measured by the consumption of sucrose out of the total consumption.
Open field test
The open field test was completed in an apparatus (100 cm × 100 cm × 40 cm in length, width and height) with the inner 50 × 50 cm 2 square designated as the central area and the surrounding part designated as the periphery. At the beginning of the test, the rat was removed from its cage and gently placed in the corner of the open field with its head facing the opposite corner. The locomotor activity (measured by line crossings), the number of rearings, the number of entries into the central area (measured by central area line crossings) and the number of grooming events were recorded. After 10 min, the rat was placed back in its cage and the device was cleaned with 70% ethanol. The experiment room was kept quiet, and the light intensity (15 lux, dim light) was maintained throughout the whole test. ethanol after each rat was tested, and all of the parameters were kept constant throughout each test.
Elevated plus maze
Oral glucose tolerance test
The oral glucose tolerance test (OGTT) was performed one day prior to killing. All rats were fasted overnight (12 h) while water was accessible, and tail vein blood was analysed with a glucometer (ACCU-CHECK Performa, Roche, Mannheim, Germany). The whole process was performed by two researchers -one held the animal securely, wiped the tail several times to clean it and obtained the blood from a tail prick, while the other prepared the glucometer and performed the measurement using glucose strips (0.6-1 l blood).
The tail of the animal was properly covered by gauze after the measurement, and the room temperature was constant during the whole process. The blood glucose level was measured before being given the oral dose of D-glucose (3 g (kg body weight) −1 , 50% concentration) and then at 30, 60, 90 and 120 min after the dose.
The homeostatic model assessment of insulin resistance (HOMA-IR) was used to assess changes in insulin sensitivity and was calculated as fasting insulin (mU l −1 ) × fasting glucose (mmol l −1 )/22.5.
Quantitative real-time PCR analysis
Total hypothalamic RNA was extracted by using Trizol reagent 
Western blot analysis
The hypothalamic tissues of the rats were lysed using RIPA buffer All specific protein band densities were normalized to -tubulin as the loading control.
Enzyme-linked immunosorbent assay
A global DNA methylation kit (cat. no. P-1030, EpiGentek, Farmingdale, NY, USA) and hydroxymethylation kit (cat. no. P-1036, EpiGentek) were used to measure the levels of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hypothalamus.
For the 5-mC measurement, the DNA samples were bound to the wells of the assay plate and washed, the detection complex solution was added, the samples were washed again, the colour developer solution was added and the absorbance at 450 nm was measured. For the 5-hmC measurement, the DNA samples were bound to the wells of the assay plate and washed, the capture antibody was added, the samples were washed again, the detection antibody and enhancer solution were added, the colour developing solution was added and the absorbance at 450 nm measured. A standard curve was used to determine the slope by using linear regression, and the percentages of 5-mC and 5-hmC were calculated using the formula: 5-mC/5-hmC = (sample OD 450 − negative control OD 450 )/(slope × nanograms of input DNA).
CLARITY and three-dimensional imaging analysis
CLARITY is a technique for making intact tissues transparent, and when combined with immunostaining it can show three-dimensional (3D) structures of tissue (Chung et al., 2013) . In our experiment the passive clearing protocol took 8-12 weeks. 3D ovarian imaging was used to quantify the numbers of follicles at different developmental stages as described previously (Feng et al., 2017) . Briefly, cold 1 × phosphate-buffered saline (PBS) and hydrogel solution were used in the perfusion, and samples were stored in hydrogel solution at 4 • C for 3-4 days. Polymerization was initiated by placing the samples in a 37 • C The methylation status of potential candidate genes is represented by the methylation of some CpG sites (YG: site 1, 2, etc), which are involved in the target sequence. PCR amplifications was prior to the pyrosequencing of target sequence. Two rounds of PCR amplifications were performed (out and in), and all of the reverse primers were biotin-labelled. The primers, length of products, target sequence and sequence primers as well as CpG site and nucleotide positions of total candidate genes used in pyrosequencing are listed. Ar, androgen receptor; Camk2b, calcium/calmodulin-dependent protein kinase type II beta chain; Esr2, oestrogen receptor 2; Lepr, leptin receptor; Pgr, progesterone receptor; Plcg1, phospholipase C gamma 1.
water bath, and the samples were transferred into clearing solution until they were transparent. Immunofluorescence staining of tyrosine hydroxylase (TH) was then performed. In brief, cleared ovaries were The processing of the raw data, including 3D rendering and spot identification, was performed with Imaris software (V9.0 Bitplane, Zurich, Switzerland).
DNA isolation and bisulfite conversion
Genomic DNA was isolated from the hypothalamus samples using the 
Determination of DNA methylation by pyrosequencing
The primers used in amplification and pyrosequencing were designed with the Pyromark Assay Design software (Qiagen, Hilden, Germany).
Two rounds of PCR amplification were performed in order to obtain the DNA products to be used in pyrosequencing. The first-and second- Table 1 .
Statistical analysis
Statistical analysis was performed in SPSS for Windows version 21.0 (IBM Corp., Armonk, NY, USA). Datasets were first assessed for normal distributions using the Shapiro-Wilk test, and all were shown to be normally distributed. The homogeneity of variance was tested, and differences between the four groups were determined by one-way ANOVA followed by Tukey's post hoc test. Only results with P < 0.05 were considered statistically significant. All numerical data are presented as means ± SD.
RESULTS
Reproductive disorders in DHT-induced PCOS rats and the effect of EA
Oestrous cycles, ovarian histology and follicle quantification and analysis were used to evaluate ovarian function. As shown in Figure 1a . We found no obvious differences in the total numbers of follicles between the four groups, but the numbers and percentages of preovulatory follicles and corpora lutea decreased significantly in the PCOS group. However, the numbers of preovulatory follicles and corpora lutea were increased after EA treatment when compared to the PCOS group (Figure 1d, e) . Taken together, these results indicate that EA has some effect on ovulation of ovarian function in female PCOS-like rats.
Metabolic disorders in DHT-induced PCOS rats and the effect of EA
Body weights in the four groups were measured once a week throughout the experiment. As shown in Figure 2a , the body weights in the DIO, PCOS and PCOS+EA groups increased significantly compared with the control group starting from the third week after DHT implantation in the PCOS and PCOS+EA groups. From weeks 9 to 12, the PCOS+EA rats received EA treatments, and their body weights decreased compared to the PCOS group in the last 2 weeks (week 11 and 12). At the end of the experiment, the OGTT was used to determine the glucose consumption capacity in peripheral insulinsensitive organs. Fasting glucose levels were lower in the DIO and PCOS+EA groups at baseline, and the blood glucose levels were higher in the PCOS group compared to the control group at 60 and 90 min and were higher in the DIO group compared to the control group at 90 and 120 min (Figure 2b) . Furthermore, the area under the curve (AUC) for glucose was increased in the PCOS and DIO groups compared to the controls, while the homeostasis model assessment of insulin resistance (HOMA-IR) levels did not show significant differences in any of the four groups (Figure 2c, d ). The number of rearings in the DIO group was decreased when compared to the control group. The number of grooming did not show a difference between the four groups ( Figure 3a) . These indicated that the PCOS rats showed depression-like behaviours that could be alleviated by EA. In the forced swimming test (a classic depression test), the immobility times in all three experimental groups were significantly longer than in the control group (Figure 3b ). In the sucrose preference test, another classic depression test, the PCOS group showed less interest in sucrose than the control and DIO groups, while EA could restore sucrose preference in the PCOS+EA group (Figure 3c ). In the elevated plus maze test (Figure 4a ), the numbers of total entries, entries into the open and closed arms, time spent in the open arms, and the number of rearings were all decreased in the PCOS and PCOS+EA groups compared to the control and DIO groups, while there was no difference between the PCOS and PCOS+EA groups in any of the parameters. The number of stretch attends among the four groups did not change. These results suggested that rats in the PCOS and PCOS+EA groups show anxiety-like behaviours and that EA has little effect on such behaviours. In all behavioural tests, rats in the PCOS group showed obvious and severe anxiety and depression-like behaviours compared to the rats in the control and DIO groups, and EA could partially rescue these abnormal behaviours.
Behavioural disorders in DHT-induced PCOS rats and the effect of EA
The global DNA methylation variation in DHT-induced PCOS rats and the effect of EA
As shown in Figure 5a , the global 5-mC levels in the PCOS and DIO groups were higher than the control group, while EA could decrease 5-mC levels in the PCOS+EA group. The 5-hmC levels in both the DIO and PCOS+EA groups were lower than in the control group, and EA Control (n=9) DIO (n=9) PCOS (n=9) PCOS+EA (n=9) Control (n=9) DIO (n=9) PCOS (n=9) PCOS+EA (n=9) Control (n=9) DIO (n=9) PCOS (n=9) PCOS+EA ( 
Pyrosequencing results of PCOS-related genes and the effect of EA
Because we observed global methylation changes in the hypothalamus, we sought to determine whether there were any changes in methylation in candidate genes that are potentially associated with PCOS. As shown in Figure 6 , selected CpG sites (Table 1) were measured to determine the methylation levels of the target genes.
The methylation levels in site 2 of the phospholipase C gamma 1 (Plcg1), calcium/calmodulin-dependent protein kinase type II beta chain (Camk2b) and progesterone receptor (Pgr) genes and site 3 of the oestrogen receptor beta (Esr2) gene were increased in the PCOS group compared to the control group (Figure 6a Values are presented as means ± SD, n = 9/group. *P < 0.05, **P < 0.01, ***P < 0.001
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Control (n=9) DIO (n=9) PCOS (n=9) PCOS+EA ( Values are presented as means ± SD, n = 9/group. *P < 0.05, **P < 0.01, ***P < 0.001 methylation might play a role in the development of PCOS and that EA might improve the symptoms of PCOS by regulating the expression of DNMTs in the hypothalamus.
PCOS is a complex disease that includes a spectrum of symptoms, and the methylation profiles are tissue-specific. Therefore, it is necessary to investigate the mechanism in different tissues. Wang et al.
(2014) and Yu et al. (2015) performed genome-wide DNA methylation studies in the ovaries of PCOS patients. The former study found that variations in methylation related to p53, NOD-like receptor, type I diabetes and inflammatory signalling pathways were associated with PCOS, and the latter study found that changes in the methylation of genes related to protein binding, transcription regulation and steroid activity were involved in the pathogenesis of PCOS Yu et al., 2015) . In another study looking at human adipose tissue, the authors found that the methylation status of the PCOS-related gene RAB5B, the type 2 diabetes-related genes PPARG and SVEP1 and the methylation-related gene DMAP1, as well as CYP1B, GPT, etc., were associated with PCOS (Kokosar et al., 2016) . A study using human granulosa cells revealed that the expression of genes associated with lipid and hormone synthesis was increased and their methylation level was decreased, which might account for the hormonal disturbances, especially androgen synthesis, in PCOS patients (Pan et al., 2018) Recently, epigenetic alterations in the hypothalamus were shown to be intimately associated with female reproduction in animal models. Alves et al. (2017) and Lomniczi & Ojeda (2016) reported that epigenetic modifications such as DNA methylation could affect GnRH neurons and thus regulate the initiation of female puberty by inhibiting the activity of kisspeptin neurons in the hypothalamic arcuate nucleus. 
Dnmt3a Dnmt3b
Control (n=7) DIO (n=7) PCOS (n=7) PCOS+EA ( Values are presented as means ± SD, n = 7/group. *P < 0.05, **P < 0.01, ***P < 0.001
Our previous studies showed that there were reproductive and neuroendocrine dysfunctions in the DHT-induced PCOS rats, while acupuncture could improve the above disorders by regulating the mRNA levels of steroid hormone receptors in the hypothalamus (Feng et al., 2012 ). In the current study, we showed that the hypothalamic global methylation level was higher in the PCOS group than in the control group, and the pyrosequencing results of Esr2 and Pgr showed that their methylation levels in the PCOS group were higher than in Control (n=7) DIO (n=7) PCOS (n=7) PCOS+EA (n=7) F I G U R E 6 Methylation status of PCOS candidate genes by pyrosequencing. (a-f) Methylation results of different CpG sites in the Plcg1, Camk2b, Ar, Esr2, Pgr and Lepr genes. Values are presented as means ± SD, n = 7/group. *P < 0.05, **P < 0.01. Ar, androgen receptor; Camk2b, calcium/calmodulin-dependent protein kinase type II beta chain; Esr2, oestrogen receptor beta; Lepr, leptin receptor; Pgr, progesterone receptor; Plcg1, phospholipase C gamma 1 might affect the reproductive phenotypes of PCOS rats by exerting their effect on the activity of GnRH neurons.
Hypothalamic DNA methylation changes have been shown to be tightly associated with metabolic disturbances such as obesity.
The activity of DNMTs is necessary for energy homeostasis, and neuronal Dnmt1-knockout mice show decreased food intake and increased energy expenditure when fed a high-fat diet (Bruggeman, Garretson, Wu, Shi, & Xue, 2018) . The expression of DNMT3a in neurons of the hypothalamic paraventricular nucleus is decreased when mice are fed a high-fat diet, and these mice present with a series of metabolic disorders such as obesity, decreased glucose intolerance and increased serum levels of leptin and insulin (Kohno et al., 2014 ).
In our current study, qRT-PCR showed that the mRNA levels of both Dnmt3a and Dnmt3b were increased in the PCOS rats compared to the control group, and this suggested that the metabolic disturbances in the PCOS group might be correlated with dysfunction of DNMTs.
Methylation changes of hypothalamic proopiomelanocortin (Pomc) as well as transcriptional factors correlated with gene methylation are also involved in regulation of metabolism. Overfeeding or a high-fat diet can cause the hypermethylation of Pomc in rats and interfere with the effect of leptin and insulin, thus leading to metabolic disturbances (Marco, Kisliouk, Weller, & Meiri, 2013; Plagemann et al., 2009 ).
Methyl-CpG-binding protein 2 (MeCP2) and specificity protein 1 (SP1) are key transcription factors that can interact with the promoter region and influence the expression of genes. Feeding post-weaning rats a high-fat diet decreases the binding of SP1 to the promoter region of Pomc (Marco et al., 2013) , and mice lacking MeCP2 in the hypothalamic POMC neurons show increased promoter methylation of Pomc , both of which cause increased food intake and obesity. Because we observed obesity and metabolic symptoms in both the PCOS and DIO groups, it is interesting to know whether the hypothalamic methylation changes in the PCOS group are the same as the above discussed of the DIO group. Firstly, the leading factor of obesity in the two groups is different. Overweight and other metabolic disorders in the DIO group are attributed to the diet while metabolic changes including higher body weight are one aspect of the syndrome but not the leading factor in the PCOS group. Moreover, the DIO group did not show obvious reproductive and behavioural changes except for metabolic disorders. Secondly, qRT-PCR and western blot results showed that the expression of DNMT3a and DNMT3b in the PCOS and DIO groups were different when compared to the control group, and pyrosequencing results indicated that most of the methylation changes of PCOS-related genes were only observed in the PCOS group. In summary, methylation changes of the hypothalamus in the PCOS group are not the same as in the DIO group, and the reason why we designed the DIO group was to exclude the hypothalamic changes that were caused by diet-induced factors.
However, much more should be investigated in order to illustrate the detailed mechanisms.
In the present study, in addition to the global hypothalamic 5-mC and 5-hmC levels, we also examined the methylation status of selected CpG sites in genes that play important roles in hypothalamic physiology and that have a close relationship with PCOS.
Phospholipase C 1 (PLCG1) belongs to the phospholipase C superfamily and plays an important role in the synthesis of two key secondary messengers, inositol 1,4,5-trisphosphate and diacylglycerol.
PLCG1 has been reported to be associated with reproduction as well as with anxiety-related behaviour, and it has an anti-depressive effect in neuronal systems (Giusti, Carroll, Abassi, & Foltz, 1999; Kusuda et al., 2013; Sette, Bevilacqua, Geremia, & Rossi, 1998) . Calcium/calmodulindependent protein kinase type II chain (CAMK2b) belongs to the serine/threonine protein kinase superfamily, and CAMK2b activity in the limbic system has been shown to be associated with the regulation of behaviour and stress responses (Novak, Seeman, & Tallerico, 2006; Runft, Watras, & Jaffe, 1999; van Woerden et al., 2009 ). It has been reported that the androgen receptor (AR) can regulate the transcription of GnRH by regulating its enhancer (Brayman, Pepa, & Mellon, 2012) , and AR has also been reported to influence human mood and behaviours through the regulation of cortical releasing factor and the hypothalamus-pituitary-adrenal axis (Wang, Kamphuis, Huitinga, Zhou, & Swaab, 2008) . Oestrogen receptor (ER , ) and progesterone receptor (PGR) have been shown to be major factors in the regulation of reproduction and behaviour through negative and positive feedback loops in specific regions of the hypothalamus (Arreguin-Arevalo et al., 2007; Goodman et al., 2011; Lund, Rovis, Chung, & Handa, 2005) . Leptin receptor is related to the secretion of luteinizing hormone, glucose and energy homeostasis, and locomotor activity (Baquero et al., 2014; Zhang et al., 2011) . Pyrosequencing results showed that the methylation status of CpG sites in Plcg1, Camk2b, Esr2 and Pgr were different between PCOS and control groups. On one hand, the higher methylation level of these candidate genes confirmed the results of 5-mC between the control and PCOS groups, which suggested that there were methylation changes in the hypothalamus of PCOS rats. On the other hand, the increased methylation level could lower the expression of corresponding molecules, thus disrupting the physiological processes mediated by these molecules. The dysfunction of CAMK2b and some steroid hormone receptors such as AR might be associated with the depression and anxiety-like behaviours seen in PCOS rats. In addition, the reduced expression of ER and progesterone receptor will affect the negative inhibition of oestrogen and progesterone on the activity of GnRH neurons and thus disrupt ovarian function. These results suggest that methylation changes in these genes might be correlated with the aetiology of PCOS. In the pyrosequencing analysis of oestrogen receptor, we checked the methylation status of both oestrogen receptor alpha (Esr1) and Esr2 genes. However, we failed to obtain a desirable outcome for Esr1 because the CpG sites in the promoter region of Esr1 are either too sparse or too dense, and the signal is also difficult to detect because of the low level. Further studies may need to investigate the methylation change of Esr1 in the hypothalamus of PCOS.
This study shows for the first time that EA might improve the symptoms in PCOS-like rats by regulating hypothalamic DNA methylation. We found changes in the global level of 5-mC and the methylation status of CpG sites in the Camk2b and Ar genes as well as changes in the expression of Dnmt3b after EA treatment. Some of the PCOS symptoms such as lack of oestrous cyclicity, increased body weight and depression-like behaviours were also improved in PCOSlike rats after EA treatment. A recent article showed that EA treatment caused thousands of gene methylation changes in the adipose tissue of human PCOS patients, and among these, 80 genes associated with PCOS were identified after matching with gene expression (Kokosar et al., 2018) . The effect of EA was also evidenced in our previous studies. One study showed that low-frequency EA (2 Hz) could normalize oestrous cyclicity by decreasing the expression of GnRH and AR in DHT-induced PCOS-like rats (Feng et al., 2009) , and in another study EA was shown to regulate neuroendocrine function by decreasing the mRNA levels of the -opioid receptor (Oprk1) and -opioid receptor (Oprm1) or by regulating hypothalamic Esr2, Pgr and kisspeptin receptor (Kiss1r) mRNA levels (Feng et al., 2012) .
Moreover, EA has been shown to improve insulin sensitivity in muscle and adipose tissues in PCOS-like rats by regulating insulin signalling (Johansson et al., 2013) . Low-frequency EA might exert its effects through the central endorphin system by inhibiting the activity of GnRH neurons in the hypothalamus, thus improving the ovulatory function of the ovary. Low-frequency EA might modulate peripheral nerve activity and affect the central nervous system through the ascending spinal pathway, which would lead to the release of numerous neuropeptides, including -endorphin. In addition, stimulation of needles in the acupoints in the abdomen and hindlimb that have the same innervation with the ovary and uterus might regulate the sympathetic nervous system and increase the blood flow in these organs, which might also be associated with the improvement of ovary function and other aspects of PCOS. Low-frequency EA with repeated muscle contractions might also modulate activity in the sympathetic nervous system in the same way as physical exercise, which might be related to the metabolic benefits such as weight loss. The behavioural improvement might be attributable to the functional regulation of calcium/calmodulin-dependent protein kinase and to the effects of EA-induced neuropeptides.
In conclusion, our study is the first to investigate the role of hypothalamic DNA methylation in the pathogenesis of PCOS and the effects of EA, providing new evidence of the regulation of DNMTs and subsequent methylation changes during this process. Further studies should be performed to determine the detailed mechanisms through which methylation is involved in the pathogenesis of PCOS and to provide more evidence to support the application of EA in clinical practice.
